1.2501
전일 마감가:
$1.295
열려 있는:
$1.32
하루 거래량:
37,008
Relative Volume:
0.43
시가총액:
$9.73M
수익:
$598.00K
순이익/손실:
$-44.93M
주가수익비율:
-0.1504
EPS:
-8.31
순현금흐름:
$-17.32M
1주 성능:
-7.35%
1개월 성능:
-2.33%
6개월 성능:
-56.07%
1년 성능:
-91.68%
Ernexa Therapeutics Inc Stock (ERNA) Company Profile
명칭
Ernexa Therapeutics Inc
전화
(617) 798-6700
주소
1035 CAMBRIDGE STREET, CAMBRIDGE
ERNA을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
ERNA
Ernexa Therapeutics Inc
|
1.2679 | 9.93M | 598.00K | -44.93M | -17.32M | -8.31 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
408.56 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
472.80 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
563.13 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
801.26 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
ONC
Beone Medicines Ltd Adr
|
331.45 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Ernexa Therapeutics Inc 주식(ERNA)의 최신 뉴스
What the charts say about Ernexa Therapeutics Inc. todayMarket Volume Report & Capital Efficient Trading Techniques - newser.com
Should I hold or sell Ernexa Therapeutics Inc. stock in 2025Earnings Growth Report & Verified Technical Signals - newser.com
Smart tools for monitoring Ernexa Therapeutics Inc.’s price action2025 Year in Review & Daily Momentum Trading Reports - newser.com
Why Ernexa Therapeutics Inc. stock could rally in 2025July 2025 Momentum & Weekly Breakout Stock Alerts - newser.com
Order flow analysis tools used on Ernexa Therapeutics Inc.2025 Volatility Report & Real-Time Chart Pattern Alerts - newser.com
Ernexa Therapeutics’ (ERNA) “Sell (E+)” Rating Reiterated at Weiss Ratings - Defense World
Historical volatility pattern of Ernexa Therapeutics Inc. visualizedJuly 2025 Pullbacks & Weekly High Conviction Trade Ideas - newser.com
How moving averages guide Ernexa Therapeutics Inc. tradingWatch List & Long Hold Capital Preservation Plans - newser.com
Can Ernexa Therapeutics Inc. stock sustain market leadershipJuly 2025 PreEarnings & Fast Gaining Stock Reports - newser.com
Custom strategy builders for tracking Ernexa Therapeutics Inc.Portfolio Profit Report & Smart Allocation Stock Tips - newser.com
Ernexa Therapeutics to Deliver Company Presentation At the Annual Cell & Gene Meeting on the Mesa - MarketScreener
Ernexa Therapeutics to Present at Cell & Gene Meeting on the Mesa, Highlighting Advances in iMSC Therapies for Cancer and Autoimmune Disease - Quiver Quantitative
Ernexa Therapeutics to Deliver Company Presentation at the Annual Cell & Gene Meeting on the Mesa - GlobeNewswire
Leading Cancer Cell Therapy: Ernexa Therapeutics to Showcase iMSC Platform at Major Industry Conference - Stock Titan
Ernexa Therapeutics: Interview With President & CEO Sanjeev Luther About The Innovative Cell Therapy Company - Pulse 2.0
Ernexa Therapeutics CEO Sanjeev Luther to Speak at 5th Annual iPSC Drug Development Summit - Quiver Quantitative
Ernexa Therapeutics President & CEO Sanjeev Luther to - GlobeNewswire
Cancer & Autoimmune Cell Therapy Pioneer: Ernexa CEO to Present iMSC Breakthroughs at iPSC Summit - Stock Titan
Ernexa Therapeutics Inc Stock Analysis and ForecastResistance Breakout Alerts & Small Investment Capital Gains - earlytimes.in
Ernexa Therapeutics (NASDAQ:ERNA) versus Savara (NASDAQ:SVRA) Critical Comparison - Defense World
Ernexa Therapeutics Inc. stock volume spike explained2025 Market Overview & Verified High Yield Trade Plans - newser.com
What analysts say about Ernexa Therapeutics Inc stockGrowth vs. Value Investing & Affordable Stock Market Tips - Early Times
Published on: 2025-09-22 07:32:05 - newser.com
Momentum divergence signals in Ernexa Therapeutics Inc. chartJuly 2025 Sentiment & Accurate Buy Signal Notifications - newser.com
Fund Flows: Will Ernexa Therapeutics Inc outperform tech stocksJuly 2025 PreEarnings & Risk Controlled Swing Alerts - خودرو بانک
Ernexa Therapeutics Inc (ERNA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Ernexa Therapeutics Inc 주식 (ERNA) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Cherington Charles | 10% Owner |
Apr 02 '25 |
Buy |
0.10 |
3,768,397 |
394,174 |
20,401,602 |
자본화:
|
볼륨(24시간):